{{ __('Your cart') }}0
0,00 £
0
items
0,00 £
Hypertension is one of the most common cardiovascular conditions affecting millions of people across the UK. It occurs when blood pressure consistently remains above 140/90 mmHg. High blood pressure often develops gradually without noticeable symptoms, earning it the nickname "the silent killer." Understanding the risk factors is essential for prevention and early management. Risk factors include age, family history, obesity, excessive salt intake, stress, and lack of physical activity. Many people discover they have hypertension only during routine medical checks, highlighting the importance of regular monitoring.
The UK market offers several effective treatments for hypertension. ACE inhibitors such as lisinopril and enalapril work by relaxing blood vessels and improving blood flow. Angiotensin II receptor blockers including losartan and valsartan provide similar benefits through a different mechanism. Calcium channel blockers like amlodipine and diltiazem help blood vessels relax, reducing pressure. Beta-blockers such as atenolol and bisoprolol reduce heart rate and force of contraction. Diuretics including furosemide and bendroflumethiazide help remove excess fluid from the body. Many patients benefit from combination therapy using multiple medications for better control.
Beyond medication, lifestyle changes play a crucial role in managing hypertension effectively. Key lifestyle modifications include:
These measures contribute significantly to better blood pressure control and reduce the need for medication escalation.
Angina occurs when the heart doesn't receive enough oxygen-rich blood, typically due to narrowed coronary arteries. Patients experience chest pain, pressure, or tightness, particularly during physical exertion or stress. Coronary heart disease develops when cholesterol and other substances build up in artery walls, gradually restricting blood flow. This serious condition increases the risk of heart attacks and requires prompt medical attention and appropriate medication. Early recognition of symptoms is vital for preventing life-threatening complications.
Nitrates represent a primary treatment, with sublingual glyceryl trinitrate (GTN) spray providing rapid relief during angina attacks. Long-acting nitrates like isosorbide mononitrate offer sustained protection throughout the day. Beta-blockers including bisoprolol and carvedilol reduce heart workload by slowing heart rate. Calcium channel blockers such as diltiazem provide additional relief and improve blood flow. Statins like atorvastatin and simvastatin reduce cholesterol and stabilise plaques. Antiplatelet medications including aspirin and clopidogrel prevent blood clots. Many patients require combinations of these medications for optimal protection.
Regular check-ups help monitor heart function and medication effectiveness. Stress testing, electrocardiograms, and angiograms provide detailed information about heart status. Avoiding smoking, managing diabetes and high blood pressure, maintaining healthy cholesterol levels, and regular moderate exercise all help prevent angina progression and reduce heart attack risk.
Heart failure develops when the heart cannot pump enough blood to meet the body's needs. Systolic heart failure occurs when the left ventricle weakens and cannot contract properly. Diastolic heart failure happens when the left ventricle becomes stiff and cannot relax adequately. Common symptoms include shortness of breath, particularly when lying down, fatigue and weakness, swollen ankles and legs, rapid or irregular heartbeat, and difficulty exercising. Early recognition and treatment significantly improve outcomes and quality of life.
The UK offers comprehensive heart failure treatment options. ACE inhibitors such as lisinopril and ramipril form the cornerstone of therapy, helping the heart work more efficiently. Beta-blockers including carvedilol and bisoprolol reduce strain on the heart. Aldosterone antagonists like spironolactone retain potassium and reduce fluid retention. Diuretics including furosemide manage fluid buildup and breathing difficulties. Newer agents such as sacubitril/valsartan combination therapy provide enhanced benefits for eligible patients. Digoxin remains available for specific patients needing additional heart rate control. Individual medication plans depend on heart failure severity and patient characteristics.
Patients must carefully monitor fluid intake, limiting liquids to 1.5-2 litres daily. Weighing yourself daily helps detect fluid retention early, allowing for prompt medication adjustments. Low-sodium diets reduce fluid accumulation. Moderate exercise, as approved by healthcare providers, strengthens the heart gradually. Avoiding smoking and alcohol protects remaining heart function. Regular monitoring appointments ensure medications remain effective and adjusted appropriately to changing conditions.
Arrhythmias encompass various abnormal heart rhythms ranging from benign to life-threatening. Atrial fibrillation represents the most common type, affecting hundreds of thousands of UK residents. The heart rate may be too fast (tachycardia), too slow (bradycardia), or irregular. Symptoms include palpitations, dizziness, shortness of breath, and fainting. Some people experience no symptoms and discover arrhythmias during routine checks. Prompt diagnosis and appropriate treatment prevent serious complications including stroke.
The UK market provides various antiarrhythmic medications tailored to specific conditions:
Individual treatment depends on arrhythmia type, frequency, and associated conditions.
Electrocardiogram, Holter monitoring, and electrophysiology studies help identify specific arrhythmia types. Some patients benefit from ablation procedures that destroy problematic tissue. Pacemakers and implantable cardioverter-defibrillators manage severe cases. Medication combinations often provide optimal results. Regular follow-up appointments ensure treatment effectiveness and allow medication adjustments as needed.
High cholesterol significantly increases cardiovascular disease risk. LDL cholesterol deposits in artery walls, creating plaques that narrow blood vessels and restrict blood flow. HDL cholesterol, conversely, removes excess cholesterol, protecting heart health. Total cholesterol above 5.2 mmol/L requires attention. Risk increases further when combined with hypertension, diabetes, or smoking. Regular cholesterol screening helps identify high levels before complications develop. Lifestyle modifications combined with appropriate medication effectively reduce cardiovascular risks.
Statins represent the most widely prescribed cholesterol-lowering medications in the UK. Simvastatin, atorvastatin, and pravastatin reduce LDL cholesterol effectively. Rosuvastatin provides potent cholesterol reduction for higher-risk patients. These medications also reduce inflammation in artery walls and stabilise existing plaques. Most people tolerate statins well, though muscle aches occasionally occur. Alternative or additional medications including ezetimibe, PCSK9 inhibitors, and bempedoic acid treat patients requiring additional cholesterol reduction or those unable to tolerate statins adequately.
Dietary modifications focusing on reduced saturated fats and increased fibre intake help lower cholesterol naturally. Regular aerobic exercise, smoking cessation, and weight management support medication effectiveness. Increasing oily fish consumption provides beneficial omega-3 fatty acids. Plant sterols in fortified foods offer modest cholesterol reduction. Annual cholesterol checks monitor treatment success and guide medication adjustments, particularly for high-risk patients requiring aggressive cholesterol management.
Peripheral vascular disease develops when artery narrowing restricts blood flow to limbs, typically the legs. Atherosclerosis causes most cases, with plaques gradually obstructing arteries. Symptoms include leg pain during walking, numbness, and difficulty healing wounds. Risk factors include smoking, diabetes, high blood pressure, high cholesterol, obesity, and sedentary lifestyle. Early detection and treatment prevent severe complications including amputation. Comprehensive cardiovascular risk reduction benefits all peripheral vascular disease patients.
Antiplatelet medications including aspirin and clopidogrel prevent blood clots. Cilostazol improves walking distance in claudication patients by improving blood flow. Statins reduce cholesterol and stabilise plaques. ACE inhibitors and beta-blockers manage blood pressure and reduce cardiovascular events. Anticoagulants like warfarin prevent clot formation in severe cases. Some patients require angioplasty or bypass surgery for optimal results. Combination therapy addressing multiple cardiovascular risk factors provides best outcomes.
Supervised exercise programmes significantly improve walking capacity and quality of life. Graduated walking programmes starting gradually and increasing duration prove particularly effective. Foot care becomes essential, checking daily for wounds and infections. Smoking cessation dramatically improves outcomes. Proper footwear prevents ulceration. Regular monitoring appointments track disease progression and medication effectiveness, ensuring early intervention for developing complications.
